STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
STAT [Unofficial]
June 8, 2026
A combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.
Discussion in the ATmosphere